Você procurou por: perinatal (Inglês - Maltês)

perinatal transmission
trasmissjoni fiż-Żmien tat-twelid

pregnancy, puerperium and perinatal
kondizzjonijiet ta’ waqt it-tqala, il-ħlas u wara l- ħlas

pregnancy, puerperium and perinatal conditions
eżitazzjoni urinarja11

embryo/foetal and perinatal toxicity
tossiċità embrio/fetali u perinatali

perinatal and postnatal developmental toxicity studies have not been conducted.
ma twettqux studji tal-effett tossiku fuq l-iżvilupp fil-perjodu madwar it-twelid u wara t-twelid.

there are no studies of foetal, developmental, perinatal or postnatal toxicity.
m’hemmx studji dwar l-effett tossiku fuq l-iżvilupp tal-fetu qabel u wara t-twelid.

in perinatal and postnatal studies in rats, piperaquine was associated with delivery complications.
fi studji ta’ qabel u wara t-twelid fil-firien, piperaquine kien assoċjat ma’ kumplikazzjonijiet waqt il-ħlas.

parental benefit same time in order to take part in a prenatal or perinatal education programme.
il-benefiċċji ta’ qabel ittwelid

specific studies addressing reproductive function, perinatal toxicity and carcinogenic potential have not been performed.
ma sarux studji speċifiċi li jindirizzaw il-funzjoni riproduttiva, tossiċità perinatali u potenzjal karċinoġeniku.

multiple gestation, especially high order, carries an increased risk of adverse maternal and perinatal outcomes.
aġġustament xieraq tad- doża tal- fsh għandu jevita li jkun hemm żvilupp follikulari multiplu. Ġestazzjoni multipla, speċjalment b’ numru kbir, iġġib magħha riskju ogħla ta ’ kondizzjonijiet avversi waqt it- tqala u waqt it- twelid.

multiple pregnancy, especially of high order, carries an increased risk of adverse maternal and perinatal outcomes.
tqala multipla, speċjalment b’ammont kbir, iġġib magħha riskju akbar ta’ effetti mhux mixtieqa għall-omm qabel, waqt u wara t-twelid.

perinatal mortality was increased and mean pup weight was decreased during the lactation period in high-dose f1 animals.
il-mortalita` fiż-żmien immedjatament qabel jew wara t-twelid kienet iżjed u l-medja tal-piz tal-ġriewi kien inqas waqt iż- żmien tat-treddigħ fl-annimali tad-doża għolja f1.

figure 1: perinatal mortality rates per 1 000 total births (2011 or most recent data)
figura 1: ir-rati tal-mortalità perinatali għal kull 1 000 twelida totali (2011 jew l-aktar dejta riċenti)

the perinatal mortality rate declined in the last five years in the majority of member states, although some countries saw the rate increase during this period.
f'dawn l-aħħar ħames snin ir-rata tal-mortalità perinatali naqset fil-biċċa l-kbira tal-istati membri, għalkemm f'xi pajjiżi din ir-rata żdiedet matul dan il-perjodu.

examination of reproductive function, of embryo/foetal and perinatal toxicity, of mutagenic potential and of carcinogenic potential shall be considered.
eżami tal-funzjoni riproduttiva, tat-tossiċità ta' l-embriju/fetu u perinatali, ta' potenzjal mutaġeniku u ta' potenzjal karċinoġeniku għandu jkun meqjus.

in a study of peri- and post-natal development in rats, retigabine was associated with increased perinatal mortality following administration during pregnancy.
fi studju ta’ żvilupp fil-firien qabel u wara t-twelid, retigabine kien assoċjat ma’ żieda fl-imwiet qabel it-twelid meta kien hemm għoti waqt it-tqala.

in the pre and postnatal development study in rats at exposures lower than those obtained in humans with therapeutic doses, voriconazole prolonged the duration of gestation and labour and produced dystocia with consequent maternal mortality and reduced perinatal survival of pups.
fl- istudju dwar l- iżvilupp ta 'qabel u wara t- twelid fil- firien f' esponimenti aktar baxxi minn dawk miksuba fin- nies b' dożi terapewtiċi, voriconazole tawwal iż- żmien tat- tqala u l- ħlas u kkawża distoċja bil- mewt konsegwenti ta' l- omm u sopravivenza mnaqqsa wara t- twelid tal- frieħ.

fertility, teratology, perinatal and postnatal studies were conducted with aztreonam for i.v. injection in rats at daily doses up to 750 mg/kg without adverse effects.
saru studji dwar il-fertilità, it-teratoloġija, u dwar il-perjodu perinatali u dak ta’ wara t-twelid, b’aztreonam għall-injezzjoni i.v. fil-firien f’dożi ta’ kuljum sa 750 mg/kg mingħajr l-ebda effetti avversi.

6.11.2 in the uk babies of asian mothers tend to have lower-birth weights than other ethnic groups and their risk of perinatal and post-natal mortality tends to be higher.
6.11.2 fir-renju unit it-trabi ta' ommijiet ażjatiċi għandhom il-ħabta li jkunu jiżnu inqas mat-twelid minn dawk ta' gruppi etniċi oħrajn u r-riskju tagħhom ta' mortalità perinatali jew postnatali għandha l-ħabta tkun ikbar.

an embryo-foetal developmental toxicity/perinatal developmental study has been performed in cynomologous monkeys at 0, 30 and 100 mg/kg (9-17 monkeys/group) and has revealed no evidence of harm to the foetuses due to adalimumab.
sar studju fuq l-effett tat-tossiċità waqt l-iżvilupp embrijo-fetali/l-iżvilupp fiż-żmien immedjatament qabel jew wara t-twelid, fuq xadini ċinomologi li b’ 0, 30 u 100mk/kg (9-17 – il xadina/grupp) u dan ma wera l-ebda evidenza ta’ dannu kkaġunat b’adalimumab fuq il-feti.